Use of photo beyond license window doesn’t create false endorsement claim

Bovinett v. HomeAdvisor, Inc., No. 17 C 6229, 2018 WL
1234963 (N.D. Ill. Mar. 9, 2018)
Bovinett, a model and actor, participated in a photoshoot
for HomeAdvisor. Bovinett’s agent was allegedly assured that the photos would
be used in static form only (i.e., either in print media or as a static image
posted on a website), and would not be incorporated into any video. Two weeks
later, Bovinett’s agent signed a consent and release form stating that Bovinett
agreed to convey his rights in the photos to HomeAdvisor for use “in
advertising, promotions, and any other use, and in any media, desired by
HomeAdvisor in its sole discretion, including but not limited to display on the
HomeAdvisor website, in television commercials, and on the Internet.”
HomeAdvisor’s personnel allegedly assured Bovinett’s agent that notwithstanding
the consent and release language, HomeAdvisor would not put the photos to use
in any video format.  Then it did.
Fraudulent inducement: Claims involving a false statement of
intent regarding future conduct are generally not actionable under Illinois law,
unless they are “particularly egregious” or are part of a larger scheme. These
alleged misrepresentations weren’t particularly egregious, nor did Bovinett
allege a pattern; two different statements about non-video use could in theory
be a pattern, but Bovinett didn’t sufficiently allege the first statement with
specificity.  Nor was fraudulent
concealment properly alleged; this requires that the defendant concealed a
material fact when under a duty to disclose that fact, but some sort of
fiduciary or confidential or other special relationship is required and none
was alleged.
Lanham Act/Illinois Consumer Fraud and Deceptive Business
Practices Act/Illinois Uniform Deceptive Trade Practices Act:  Bovinett failed to allege any false
statement.  And the likely confusion
claims failed because there could be no confusion about Bovinett’s affiliation,
sponsorship, or approval of defendants and/or their activities and services. “Bovinett
admits he agreed to pose as a model for HomeAdvisor’s photoshoot with the
knowledge that HomeAdvisor intended to use those photos in advertising. … [T]he
allegedly tortious commercials might well leave viewers with the impression
that Bovinett endorses HomeAdvisor. But that impression is accurate, at least
as of the time Bovinett sold his rights in these photos, so the impression
cannot confuse anyone.”  The court doesn’t discuss the rump confusion theory that viewers would be
confused about whether he authorized video use—which could hardly be material
to anyone, even if for some extremely unlikely reason the matter occurred to them.

from Blogger http://ift.tt/2p6NiTk

Posted in Uncategorized | Tagged | Leave a comment

Redbox’s claims miss release window for injunctive relief

Redbox Automated Retail, LLC v. Xpress Retail LLC, 2018 WL
1240345, No.17 C 5596 (N.D. Ill. Mar. 9, 2018)
The parties compete in the market for DVD rental services
through automated vending machines called kiosks. “In early 2016, Redbox
learned that DVDXpress was using kiosks that were, like Redbox’s, entirely red
in color. Around the same time, Redbox also learned that DVDXpress was
advertising—on its kiosks, its website, and elsewhere—that customers could rent
movies through DVDXpress twenty-eight days before the same DVDs became
available through Redbox.”
Nearly a year later, one Redbox official wrote in an email,
“I think that’s false advertising[.] We are day and date for most,” then asked
the CEO whether DVDXpress’s red kiosks infringed Redbox’s “trademarks or other
IP.” The CEO replied: “No it does not. We have looked at [sic] many times.
Nothing we can do except get these locations.” Four months later (15 months
after learning of the comparative advertising) Redbox sent a C&D.  More than three months after that, Redbox
sued. 
Given this recitation of the facts, you won’t be surprised
to learn that a preliminary injunction was denied due to Redbox’s delay.  The court didn’t even consider whether eBay changed the Lanham Act presumption
of irreparable injury (it does) because the delay would rebut any presumption.
Redbox argued that, at first, only lower-level employees
knew of DVDXpress’s alleged infringement. “But that assertion is not backed by
evidence in the record, and in any event Redbox does not explain why it would
be relevant to determining when it, as a company, learned of the infringement.”  The email from the CEO stating that the
company had already looked “many times” into the matter of DVDXpress’s red
kiosks and concluded that there was no infringement was only icing; it showed
that Redbox was “well aware of [its] rights and had concluded that they were
not violated.”
Redbox argued that it didn’t delay in bringing the false
advertising claim because it sought relief based only on DVDXpress’s
advertising regarding DVDs released between December 2016 and July 2017. But
the content of DVDXpress’s advertising—“Rent it here first 28 days before …
Redbox”—hadn’t changed since early 2016. 
Redbox argued that DVDXpress’s comparative advertising was only
“partially false” in early 2016, and that Redbox brought suit when the
advertising became false as to more DVDs through new agreements with Warner
Bros., Fox, and Universal Pictures decreasing the delay between a DVD’s release
and its availability at Redbox kiosks.  If there had been a 28-delay for all such
films in early 2016, then waiting to sue would have been a good idea.  But of the 24 recent movies Redbox claimed to
have available within 28 days, only 8 were distributed by these studios.  There was no evidence that DVDXpress’s
advertising as to those studios’ DVDs was any less false in early 2016. And
even as to those studios, Redbox was releasing some DVDs from them earlier—five
out of the 8 it named were distributed before the new agreement. Thus, the
comparative advertising couldn’t have converted to “substantially false” as a
result of those agreements.  Indeed, the
emails showed that people at Redbox believed the advertising was false in early
2017.
Nor would the court stop the clock when Redbox sent its
C&D. “If the letter had led to negotiations with DVDXpress, then Redbox
perhaps could not be faulted for waiting to see if the dispute could be
resolved out of court. But DVDXpress never answered the letter, and Redbox
proceeded to wait a further three months before filing suit.” That delay “severely
undermines any sense of urgency that might otherwise have attached to Redbox’s
request for preliminary injunctive relief.”

from Blogger http://ift.tt/2HsnojV

Posted in Uncategorized | Tagged , , | Leave a comment

Pod save the claim: “sportspods” competition leads to false advertising, TM claims

Anthem Sports, LLC v. Under the Weather, LLC, 2018 WL
1175406, No. 17cv596 (D. Conn. Mar. 6, 2018)
Anthem and UTW compete in the market for “sportspods,” small
tents for viewing outdoor sporting events during inclement weather. I won’t
discuss the claims for declaratory relief against potential violations of UTW
patents.
Anthem initially distributed UTW products online under an
exclusive distribution agreement, until the relationship collapsed and UTW
turned to Dick’s Sporting Goods for distribution. “Anthem subsequently located
a different manufacturer and “began offering all weather personal enclosure
products under the trade names UnderCover™ and SportPod™, including SoloPod™,
Action Pod™, TeamPod™, and BugPod™.” UTW then allegedly began using “the mark
‘Sportspod’ to refer to multiple goods” that it offered for sale.  UTW also allegedly threatened Anthem, its
supplier, and customers with patent infringement claims.
On Facebook, when customers leave comments indicating a
desire to purchase Anthem Pods on Anthem’s Facebook page, UTW’s representatives
allegedly respond (i) that the “only place to get [Anthem Pods] is
undertheweatherpod.com,”; (ii) that the Anthem Pods “are illegal knockoffs and
very poor quality,” and that the “legal ones are only available at
undertheweatherpods.com”; and (iii) that the Anthem Pods were “[Pescovitz’s]
idea and patent”; (iv) and that the Anthem Pods are “complete knock offs.” (Couldn’t
UTW’s reps just be blocked?)
Based on this conduct, Anthem brought a false designation of
origin claim, a false advertising claim, and a trademark infringement claim.
Guess which survived!
For false designation of origin, the court found that Anthem
hadn’t properly alleged a reverse passing off claim.  Misrepresentations of inventorship aren’t
actionable under Dastar.  The alleged claims that Anthem pods could
only be bought from UTW were really statements that the Anthem pods were are “knockoffs”
or of “inferior quality,” and that the only place to get legal “pods” was from
UTW’s website. These comments couldn’t plausibly be interpreted to suggest that
UTW sold Anthem Pods but rather presents UTW as an alternative.
False advertising: The “knockoff” and “poor quality”
statements were mere statements of opinion, not fact.  The “illegal” and “patent infringing”
statements were also nonactionable layperson statements of legal opinion.  “Complete knockoffs” was both opinion and
puffery via subjective hyperbole.
Trademark: claims based on UTW’s use of SportsPod and
Anthem’s claimed SportPod mark survived. 
[Since the judge in this case identified the products at issue as
“sportpods,” I foresee a problem with this term as a mark for the products.]
Anthem also sufficiently alleged tortious interference (and
common law unfair competition) from UTW’s allegedly disparaging statements on
FB, including an allegation that UTW made these comments with full knowledge of
the lack of “any legitimate basis” for them and in “bad faith to unlawfully
stifle competition.”  Instead of
identifying specific lost customers, what was required was facts demonstrating
“that, except for the tortious interference of the defendant, there was a
reasonable probability that the plaintiff would have entered into a contract or
made a profit.” The complaint alleged that various potential customers have
expressed interest in purchasing Anthem Pods on Anthem’s Facebook page, and the
majority of the disparaging comments were aimed at customers who had expressed
enthusiasm for Anthem’s products. 
Targeting “enthusiastic potential customers” made it plausible that some
of them didn’t buy Anthem pods due to UTW’s statements.
Connecticut’s unfair trade practices law, CUTPA, also
allowed a state coordinate trademark infringement claim, but not a false
advertising claim for the reason discussed above.  Anthem also alleged that UTW violated CUTPA
by “inducing Anthem to invest significant resources and efforts in marketing
and selling the UTW Personal Enclosures by promising Anthem that it would be
the exclusive distributor for such products other than UTW and then selling the
UTW Personal Enclosures to Dick’s Sporting Goods for resale.”  UTW argued that, even if accepted as fact,
these allegations established little more than breach of contract.  However, “although “a simple breach of
contract would not be within the criteria for a CUTPA claim, substantial
aggravating circumstances attending the breach would sustain such a claim,” and
Anthem alleged sufficient aggravating circumstances by adding to the alleged
breach trademark infringement and baseless infringement threats against Anthem
when the company attempted to sell its own products in lieu of those from UTW.

from Blogger http://ift.tt/2p1Z9l6

Posted in Uncategorized | Tagged , , | Leave a comment

unauthorized sale of model’s photos leads to internally inconsistent TM/ROP ruling

Passelaigue v. Getty Images (US), Inc., 2018 WL 1156011, No. 16-CV-1362 (S.D.N.Y. Mar. 1, 2018)

Elodie Passelaigue is a professional fashion model who sued under the Lanham Act, Washington state law, and New York law against Getty, Bill Diodato Photography, and Bill Diodato (no stranger to IP litigation) for unlawfully licensing and selling images of her that were eventually used to advertise synthetic beauty products. The court dismissed some claims but allowed others to continue.

As part of one advertising campaign in early 2004, Clinique arranged for a test photo shoot in New York, and hired Diodato to take the photos. After the test shoot, Diodato allegedly “asked Ms. Passelaigue if he could use photos from the test shoot for his portfolio and professional website simply as an example of his work.” He allegedly “showed her a form document titled ‘Model Release,’ representing to Ms. Passelaigue that if she was willing to allow him to use the photos only for his portfolio and website, she just needed to sign the Model Release form.” Passelaigue allegedly agreed to allow him to use the photos for his website “[a]s a professional courtesy.” The Release she signed allegedly didn’t have some important information, including photographer or witness signatures, a “Description of Shoot,” or an attached copy of a photo ID or “Visual Reference.”

In 2009, Passelaigue was hired to model for a photo shoot in New York for Spiegel, and Diodato photographed that shoot. Diodato allegedly took about a dozen headshots of Passelaigue without Spiegel’s consent, and told Passelaigue the headshots were “precautionary, in case Spiegel later decided it wanted to use the images for the cover of a catalog.” Passelaigue didn’t sign anything at the 2009 Spiegel photo shoot.

In 2014, Passelaigue learned for the first time that her headshots were being used for an advertising campaign for Botox and on an Allergan website, http://www.skinmedica.com.  The webpages allegedly falsely suggest that Passelaigue was at least in her 40s.  Allergan allegedly continued to use Passelaigue’s images in its advertising campaigns until 2016.  Passelaigue’s agent investigated, and eventually Getty provided a copy of the Release containing a handwritten date of “6-11-09” under her name, and the phrase “Clinique Underwater Shot [sic] & Spiegel Beauty” on the line designated for “Description of Shoot,” both written by someone else. This Release also included two sample headshots, one from each shoot.  Getty eventually identified the photographer as “Adrianna Williams,” who was selling other models’ photographs through Getty, but other models hadn’t heard of her either, and Passelaigue determined that the photographer was in fact Diodato.

The court found the release binding as to the 2004 Clinique shoot only, since Passelaigue conceded that she signed it; the plausible allegations of “doctoring” the release sufficed to continue the case for the 2009 photos.  Passelaigue argued that she was fraudulently induced to sign the original Release because
Diodato orally promised her that he would only use her photographs in his portfolio and on his website.  However, the release language was two paragraphs of super-broad language allowing the photographer to distribute the images “for editorial, trade, advertising, packaging or other purposes in any manner or medium … throughout the world, in perpetuity.”  It further said, “I understand Photographer may contract with a stock agency and that the images may be included in stock files. I further understand and agree that the images may be modified, altered, cropped and combined with other content such as images, video, audio, text and graphics.”  Because the alleged misrepresentations conflicted with the terms of the Release, “there can be no reasonable reliance as a matter of law.”

Nor was the Release voidable because, “for a high-end fashion model, the limitation of $500 in damages, as well as the prohibition on any objection to unflattering, embarrassing, or otherwise objectionable uses, are unconscionable terms.” Although the allegations in the complaint suggested “some deceptive tactics,” they didn’t rise to the level of depriving Passelaigue of “meaningful choice,” as required for unconscionability.  “The Release is short—one page—and afforded Plaintiff with the opportunity to easily disprove Diodato’s alleged oral promises that he would only use the photographs for his portfolio.” Passelaigue didn’t allege that her bargaining power, experience, and/or education were limited, or that she was under any sort of duress or pressure to sign the release without reading it, and she admitted that she signed it as a “professional courtesy.” Thus, there were no allegations that Diodato did anything so as to effectively deprive Passelaigue of a meaningful choice.

The same arguments disposed of her fraud claim.

Continuing on with the 2009 photos, the court turned to her NY right of publicity claim.  Defendants argued that the photographs weren’t used “for purposes of advertising or trade” under Section 51 because they were merely making the images themselves available for license.  But an image for sale by an online image distributor is exempt from Section 51 liability only so long as it was “for use in a manner lawful under this article.” Because Passelaigue plausibly alleged that the sale of images was not in fact “for use in a manner lawful under” Section 51 by virtue of the fact she did not knowingly authorize their use, and she also adequately alleged that sale of the images themselves was “for purposes of advertising or trade.” 

The court also disposed of defendants’ First Amendment defense.  “The photographs here are entirely commercial in nature. They were commissioned by companies seeking to use them in advertising campaigns, and any artistic expression added by Diodato as the photographer was incidental.” Nor was Section 51 preempted by §301 of the Copyright Act, because of the additional element of use of the image for advertising or trade purposes without written consent.

Passelaigue’s Lanham Act claims mostly failed.  Her allegations were that defendants violated the Lanham Act by (1) misrepresenting that Getty had the right to license or sell photographs of her; (2) using the fictitious name of Adrianna Williams as the name of the photographer, which was likely to cause confusion as to the origin of the images; and (3) contributing to Allergan’s use of her image in a way that falsely associates her with synthetic cosmetic products.

However, Passelaigue had no rights to the photos themselves.  “[H]er only plausible claim can be based on harm to her image, and its false association with another product.” Thus, alleged misrepresentations (1) and (2), as well as allegations that Diodato contributed to Getty’s acts, failed to state a claim; even if she did have rights to the photos, Dastar would bar those claims.

Turning to claims based on false affiliation with Allergan and with the pseudonym Adrianna Williams, the court noted that “the misappropriation of a completely anonymous face could not form the basis for a false endorsement claim, because consumers would not infer that an unknown model was ‘endorsing’ a product, as opposed to lending her image to a company for a fee.” However, Passelaigue’s allegations she is an “internationally-renowned fashion model” might establish that her mark is strong enough to cause a likelihood of consumer confusion.  In addition, the sale of images of Passelaigue on Getty’s stock photo website and its listing under the work of photographer “Adrianna Williams” were affiliations that are covered by the text of the Lanham Act. [How could this possibly be material to anyone?  Also, if Diodato really did take the pictures, why can’t he use a pseudonym without violating the Lanham Act? Are other pseudonyms also violations of the Lanham Act?  Also also, why isn’t this conduct, which is to say a false designation claim repled as “affiliation” with Getty or Williams, covered by Dastar too?]

As for contributory infringement, Passelaigue failed to sufficiently allege that defendants intentionally induced non-party Allergan to violate the Lanham Act, as required. She alleged that Diodato was aware that, by selling the images to Getty, that Getty would “use the images commercially, advertising them for sale or license to others, such as Allergan,” and that Getty “knew or should have known that professional models such as plaintiff … would not have agreed to convey rights to their images to Diodato, Getty, or ultimately one of Getty’s clients.” She further alleged that Getty should have known how Allergan would use the image because it licensed that image. None of this was sufficient to allege intentional inducement. (Citing Tiffany v. eBay.)

Anyway, the NY unfair competition claims were analyzed just as the Lanham Act claims, except that NY also requires bad faith.  But Passelaigue’s allegations of defendants’ responsibility for the unauthorized use by Allergan would show bad faith.  [Wait one second: weren’t those the allegations just found insufficient to allege contributory infringement?  If NY law is the same as federal law, how can this be the case?]

As for NY consumer protection law under Section 349, allegations that Getty misrepresented its right to license were too conclusory to state a claim, or explain how the alleged misrepresentation actually targeted or harmed consumers.

The court refused to dismiss class allegations at this stage of the case.

from Blogger http://ift.tt/2FECLs0

Posted in Uncategorized | Tagged , , , , | Leave a comment

Falsity claim isn’t the ticket for cancelled concert

Universal Attractions, Inc. v. Live Nation Entertainment,
Inc., 2018 WL 1089747, No. 17 Civ. 3782 (S.D.N.Y. Feb. 12, 2018)
Universal, an entertainment company, produced the I Love the
90’s tour, a series of concerts by various artists from the 1990s. Universal
engaged promoters throughout the US to work with Ticketmaster to market and
sell tickets to the show. Prices for the tickets ranged from “the low $20s to
hundreds of dollars depending on seating and perks offered[.]” For the Vina
Robles Amphitheatre in Paso Robles, tickets were priced to be sold for $65,
$75, and $150, along with a group of VIP tickets set to be sold for the PR
Venue, which ranged from $250 to $375 per ticket.
Ticketmaster sold tickets in two phases: pre-sales (before
availability to the general public) and general sales.   For pre-sales, “a select group of consumers
were given codes through e-mail, social media, or other means that could then
be used to unlock the relevant pre-sales offer.”  For at least two venues, Ticketmaster only
listed VIP tickets in the pre-sale period; those with the codes could access
and buy the cheaper tickets, but members of the general public only saw the VIP
tickets.  As a result, Universal alleged,
fans were “turned off” and the number that left Ticketmaster’s site without
purchase was uniquely high, and the conversion to sales was uniquely low.  The Pasa Robles operator ultimately cancelled
the show due to the lower than expected volume of ticket sales.
The court rejected Universal’s argument that Ticketmaster
deceived members of the general by presenting them with only the VIP tickets
during presales, causing them to leave without purchasing any tickets and not
return because they believed that the VIP ticket prices were the only ones
available.  Failing to disclose
information isn’t literally false, and it isn’t misleading unless it renders any
affirmative statements false or misleading. But “the lack (or presence) of
tickets at prices lower than the VIP tickets on Ticketmaster’s website during
presales has no bearing whatsoever on the veracity of the VIP ticket prices
themselves.” 
This reasoning seems to me to avoid the challenge of
Universal’s argument, which is that the list of available tickets for a
particular show implicitly (mis)represents that these are not just the
available tickets, but the full range of tickets that will be available, especially for members of the general public who
believe, correctly, that they can’t buy tickets at present.  That is, the listed prices implicitly represent
that these are the only sets of tickets which members of the public may be able
to buy once general sales begin.  Thus,
the listed prices became misleading
because of the context.   That is certainly plausible—most events, after
all, want you to come, and it seems logical that they’d advertise the cheap
available tickets if there were any to be had. 
Sufficient disclosure could have come in other ways than in listing all
the different prices that tickets would be available at in the future, though
that’s one way to do it.  But the key
point, reinforced by the alleged behavior of consumers in not bothering to
return to the site after sales began, is that ticket-buying consumers presume
that information about what tickets will be available when the sales begin is
complete information.

from Blogger http://ift.tt/2tj6VMz

Posted in Uncategorized | Tagged | Leave a comment

Article in Judges’ Journal is opinion, not actionable under defamation or false advertising law

Board of Forensic Document Document Examiners, Inc. v. American
Bar Ass’n, No. 17 C 01130, 2018 WL 1014510 (N.D. Ill. Feb. 22, 2018)
The Board of Forensic Document Examiners, and seven of its
members, alleged defamation by an article appearing in The Judges’ Journal,
published by the ABA. Members of the Judicial Division of the ABA receive a
complimentary subscription to the Journal. In August 2015, a special issue titled
Forensic Sciences – Judges as Gatekeepers focused on various subjects of
forensic science that judges might encounter when qualifying experts. One
article, Forensic Handwriting Comparison Examination in the Courtroom, was
written by defendant Thomas Vastrick, who is a forensic document examiner
certified by a different board, namely, defendant American Board of Forensic
Document Examiners. Vastrick also sits on the board of the American Board and
is one of its past presidents. The court commented that he really should have
disclosed that affiliation, but still there was no viable cause of action.
The plaintiffs challenged four statements as
defamatory/false light invasion of privacy/false advertising under state and
federal law:
An appropriately trained forensic
document examiner will have completed a full-time, in-residence training
program lasting a minimum of 24 months per the professional published standard
for training. Judges need to be vigilant of this issue. There are large numbers
of practitioners who do not meet the training standard.
The American Board of Forensic
Document Examiners … is the only certification board recognized by the broader
forensic science community, law enforcement, and courts for maintaining
principles and training requirements concurrent with the published training
standards. Be wary of other certifying bodies.
In a section captioned, “What to
look out for,” the statements, “Certified by board other than the American
Board of Forensic Document Examiners” and “Member of American Academy of
Forensic Sciences but not the Questioned Document Section.”
Plaintiffs challenged these statements as false based on the
required training standards for certification, their specific backgrounds, and
the courts’ previous acceptance of practitioners certified by the Board. The
author and editor allegedly knew that the statements in the article were false,
because both knew that the Board and the American Board were each certified by
the same accrediting entity, and that the Board abided by published training
standards for certification.
Defamation: An actionable statement must sufficiently
identify the person who is being criticized to a “reasonable individual”
reading the statement. If “extrinsic facts and circumstances” are needed to
show that a statement refers to a particular plaintiff, it’s not defamation per
se. The challenged statements didn’t identify any particular person by name,
let alone any of the plaintiffs. Plaintiffs argued that this was group defamation:
a statement can identify the persons in the group if the group is “sufficiently
small and the words may reasonably be understood to have personal reference and
application to any member of the group.” Plaintiffs’ group was around 12
diplomates certified by the Board.  But
that wasn’t enough, because the first challenged statement could reasonably be
interpreted to refer to any forensic document practitioner who has not
completed the specified training program—not just the twelve examiners
certified by the Board. It even says, “There are large numbers of practitioners
who do not meet the training standard.”
So too with the second and third statements, which promoted
the American Board without explicitly naming the Board.  Plaintiff Sulner claimed that he was the
specific target of the fourth statement, “look out for” someone who is a “Member
of American Academy of Forensic Sciences but not the Questioned Documents
Section.” Sulner alleged that he was the only certified forensic document
examiner “known to be” a member of the American Academy of Forensic Sciences
but not a member of the Questioned Documents Section (because members can only
be in one section and as an attorney he was in the Jurisprudence section). But anyone who is a member of the American
Academy of Forensic Sciences but not the Questioned Documents Section fit into
the statement.  Also, Sulner didn’t
allege that a reasonable reader somehow has access to all the relevant
information and thus would interpret the statement to target him. “Even if some
extraordinarily enterprising reader of The Judges’ Journal pieced all of that
together, where a ‘speaker is meticulous enough to preserve the anonymity of an
individual … the speaker should not be exposed to liability for defamation
because someone ferrets out the identity of the individual.’”
Separately, the statements constituted non-actionable
opinion.  The court first framed the
overall context: it’s a “scholarly” journal, setting the stage for the article
to be received as opinion, “because reasonable readers (especially judges) know
that scholarly journals often present one side or the other in opinionated
debates.” And the relevant article explicitly presented itself as offering
suggestions for judges to consider in evaluating the expertise of document
examiners. The intro for “What to look for” and “What to look out for” “employs
the language of opinion, not hard facts”: “While judges are responsible for
being court gatekeepers, I, as a practicing forensic document examiner, would
like to respectfully suggest ways to differentiate between the true
professional and the lesser-qualified practitioners.” The entire section of the
article was called, “Gatekeeping Tips from a Practitioner,” indicating that
this is the author’s viewpoint.  
The individual statements also used the language of opinion,
such as “appropriately trained
forensic document examiner” (emphasis added), and “recognized by the broader
forensic science community, law enforcement, and courts ….”  There was no way to verify the American
Board’s “recognition” in the community, and the sweeping breadth of the
statement made it even less fact-like/verifiable.  The third and fourth statements were part of
the section “What to look out for,” which already spoke in the language of an
opinion. And the intro sentence says that the author “suggests” that judges
look for certain things to distinguish between a “true” professional and “lesser”-qualified
practitioners. “Suggests,” “true,” and “lesser” “all signify that Vastrick is expressing
his opinions in offering the lists.”
Without a factual statement, the false light and state-law
false advertising claims also failed, as did the Lanham Act claim–without even needing to address the question of whether the article constituted “commercial advertising or promotion.”

from Blogger http://ift.tt/2GNdTeL

Posted in Uncategorized | Tagged , , | Leave a comment

NY AG proceeds against Charter for throttling providers while boasting of internet speeds

 People v. Charter Communications, Inc., No. 450318/2017
(N.Y. Sup. Ct. Feb. 16, 2018)
Charter allegedly defrauded New York consumers by promising high-speed
Internet services and reliable access to online content that it knew it couldn’t
or wouldn’t deliver, in violation of Section 53(12) of the NY Executive Law and
sections 349 and 350 of the GBL.  Defendant Spectrum-TWC advertised specific
Internet speeds, available in tiers ranging from 20 to 300 megabits per second
(Mbps), with higher fees for faster-speed tiers. Spectrum-TWC assured
subscribers not only that they could achieve the advertised speeds, but that
subscribers were guaranteed “reliable Internet speeds,” delivered “consistently,”
“without slowdowns,” and otherwise without interruption. Spectrum-TWC assured
subscribers that the promised speeds would be delivered anywhere in their
homes, at any time, and on any number of devices, regardless of whether the
subscriber connected by wire or wirelessly.
However, for many customers, the promised Internet speeds
were allegedly impossible to attain because of technological bottlenecks for
which Spectrum-TWC was responsible. First, defendants determined that the older
generation modems they leased to many of their subscribers were incapable of
reliably achieving Internet speeds of even 20 Mbps per second. Spectrum-TWC’s modem
“replacement” program allegedly resulted in 900,000 subscribers continuing to
pay for promised speeds beyond the technical capabilities of their Spectrum-TWC-provided
modems, as Spectrum-TWC knew.
Second, Spectrum-TWC also failed to maintain its network as
necessary to deliver the promised speeds. Although Spectrum-TWC allegedly knew
the precise levels of network congestion at which customers would be prevented
from achieving the promised speeds, it deliberately hid and exceeded those
congestion levels to save itself money.
Third, due to older or slower wireless routers it provided,
and other technological limitations, Spectrum-TWC allegedly knew that its
subscribers could not achieve the same speeds wirelessly as through a wired
connection, as confirmed by at least three independent tests of Internet speed.
Next, Spectrum-TWC allegedly represented that its
subscribers would receive reliable, uninterrupted access to the Internet content
of their choice, but failed to deliver on these promises. Spectrum-TWC’s
assurances of reliability were allegedly specific and unconditional,
guaranteeing access to specific content with “absolutely no buffering,” “no
lag,” “without interruptions,” and with “no downtime.” “These promises were
explicitly tied to the delivery of some of the Internet’s most popular content,
including Netflix and online games, and Spectrum-TWC’s advertisements
prominently featured such content as being accessible without interruption.” Yet
Spectrum-TWC allegedly failed to maintain enough network capacity in the form
of interconnection ports (where one network connects to another) to deliver
this content as promised. It also allegedly “throttled” access to Netflix and
other content providers by allowing those interconnection ports to degrade,
causing slowdowns, then extracted payments from those content providers as a condition
for upgrading the ports. Spectrum-TWC’s subscribers thus suffered, generating thousands
of consumer complaints to NY’s AG.
The FCC regulates broadband Internet access service (BIAS)
providers like defendants in various ways, including requiring them to “disclose
accurate information regarding the network management practices, performance,
and commercial terms of [their] broadband Internet access services sufficient
for consumers to make informed choices regarding use of such services.” They
must disclose “expected and actual access speed and latency,” as well as
accurate monthly subscription rates and usage-based fees. The FCC established a
“safe harbor” program called Measuring Broadband American (MBA) to “measure the
actual speed and performance of broadband service,” and stipulated that a BIAS provider
could satisfy the transparency standard by “disclos[ing] data from the project
showing the mean upload and download speeds in megabits per second during the ‘busy
hour’ between 7:00 p.m. and 11:00 p.m. on weeknights.”  The FCC’s 2015 Open Internet Order states that
the FCC “expect[s] that disclosures to consumers of actual network performance data
should be reasonably related to the performance the consumer would likely
experience in the geographic area in which the consumer is purchasing service.”
The FCC also created a “Broadband Nutrition Label,” a second “voluntary safe
harbor for the format and nature of the required disclosure to consumers,”
modeled on nutrition labels used for food products. BIAS providers provide
consumers with the format for an easy-to-understand label that discloses a
service plan’s “typical speed[s],” i.e., “typical speed downstream,” and “typical
speed upstream,” which reflect averages measured during the peak usage period
of the service”
However, FCC regulations clarify that the provider could
still be found in violation of federal law if the content of the disclosure is “misleading
or inaccurate,” or if the provider “makes misleading or inaccurate statements
in another context, such as advertisements or other statements to consumers.”
TWC-Spectrum argued that it advertised only “up to” certain
maximum speeds (as measured in Mbps), and that it relied on the FCC’s safe
harbor to substantiate these performance claims. TWC-Spectrum further asserts
that the MBA reports regularly showed that its actual speeds, based on mean or median
peak-period speeds,met or exceeded the maximum advertised speeds. TWC-Spectrum also
participated in the FCC’s safe-harbor consumer labeling program.
The court rejected defendants’ conflict preemption argument.
They contended that the central allegation underlying the complaint is that Spectrum-TWC
failed to deliver the broadband speeds advertised to its customers, but this allegation
depended on methodologies for calculating actual broadband speeds starkly
inconsistent with the federal methodology. “[T]he ‘starting presumption is that
Congress does not intend to supplant state laws,’ unless its intent to do so is
‘clear and manifest,’” especially for state efforts to enforce consumer
protection laws. Spectrum-TWC didn’t identify any statutory provision that
preempts state anti-fraud or consumer-protection claims, and indeed there was a
broad savings clause.
“An administrative agency cannot exceed the authority
Congress has granted it,” so the FCC couldn’t preempt state consumer protection
law either. Though defendants argued that NY’s contentions “thwart[]” the FCC’s
purposes and objectives in promulgating the Transparency Rule, and that it would
be “impossible for broadband providers in New York to rely on the FCC’s safe
harbors without running afoul of state law,” “the FCC’s purposes and objectives
are irrelevant to the preemption analysis where, as here, Congress has
expressly preserved state laws.” Plus, the Transparency Rule recognizes
concurrent state authority over deceptive practices; although the Transparency
Rule requires certain performance disclosures by BIAS providers, it doesn’t
provide a safe harbor for statements outside those disclosures. The Rule provides
a limited federal “safe harbor” from FCC enforcement actions on transparency
grounds for broadband providers who participate in the MBA program, insofar as their
official disclosures comply with the “format” specified by the FCC. But there’s
no insulation from liability for misrepresentations made in other consumer
communications; the FCC specifically explained that “providers may still be in violation
of FCC rules if the content of their labels is misleading or inaccurate or if
they make misleading or inaccurate statements to consumers in ads or elsewhere,”
and that “a provider making an inaccurate assertion about its service
performance in an advertisement, where the description is most likely to be
seen by consumers, could not defend itself against a Transparency Rule
violation by pointing to an ‘accurate’ official disclosure in some other public
place.”
Separately, Spectrum-TWC’s preemption argument didn’t apply to
the claims relating to modem failures, wireless failures and service
reliability failures, because those claims were entirely unrelated to
Spectrum-TWC’s Transparency Rule disclosures, as well as claims relating to
service failures in the 100, 200, and 300 Mbps plans, which weren’t comprehensively
measured by the MBA program, and were thus not part of Spectrum-TWC’s Transparency
Rules disclosures. As for the remaining claims, “the FCC’s goal of promoting
competition through the Transparency Rule is not thwarted by state laws that
require broadband providers to speak truthfully.” New York’s laws don’t require
Spectrum-TWC to disclose anything, but only demand that defendants refrain from
fraud, deception, and false advertising when communicating with New York
consumers.
What about the NY AG’s alleged use of “metrics that cannot
be squared with federal law, which looks to the average peak-period speeds
measured by the MBA as the appropriate way to measure and describe actual
broadband performance”? First, many of the allegations of the complaint explained
why the disclosures were deceptive, without reference to particular speed tests.  Second, NY wasn’t challenging the “typical
speed downstream” and “typical speed upstream” disclosures made by Spectrum-TWC
in the format specified by the Transparency Rule, but rather its TV ads ads in
other media “that conveyed the overall impression that subscribers would have ‘consistent’
or ‘reliable’ service at the speeds advertised for the plans that they paid
for.” There was conflict with the purposes and objectives of the Transparency
Rule.
Defendants also argued that federal law preempts state
regulation of interconnection disputes, and that NY was trying to do so by
alleging that Spectrum-TWC deceived its customers by “fail[ing] to maintain
sufficient ports at its interconnection points with backbone and content
providers” and knowingly causing “interruptions and slowdowns during peak hours.”
This argument was “baseless.” NY wasn’t trying to regulate bilateral agreements,
but regulating Spectrum-TWC’s advertising that specific online content would be
swiftly accessible through its network, while it was simultaneously
deliberately allowing that service to degrade that service and failing to
upgrade its network’s capacity to meet demand for this content.  An internal email, for example, observed that
the company’s approach to intentionally delaying capacity upgrades “may be
artificially throttling (subscriber] demand.”
Next, Spectrum-TWC argued that it advertised its broadband
service plans as providing speeds “up to” a particular speed, so reasonable consumers
should have expected to receive the advertised speeds or less.  That conflicted with NY law on “up to” claims
where, as alleged here, the advertised “up to” speeds were functionally
unattainable as a result of the defendants’ knowing conduct. In a consumer
fraud action, the phrase “up to” does not reflect a maximum, but expresses a
representative amount a consumer would receive. The NY AG alleged this to be what
consumers expected, and also that Spectrum-TWC knew it couldn’t meet those
expectations. FTC pronouncements are persuasive authority in the context of
consumer protection suits brought under GBL sections 349 and 350, and the FTC
interprets “up to” language similarly.
Spectrum-TWC argued that its statements about speeds,
reliability and access to content were mere “puffery.” It cited claims to have
a “blazing fast, super-reliable connection” and campaigns that said “[e]njoy
Netflix better” or “[s]tream Netflix and Hulu movies and shows effortlessly.” But
“advertising claims that are easily capable of being proved to be true or false
through common testing methodologies are, by definition, not puffery,” and statements
such as “no buffering,” “no lag,” with “no slowdowns,” “without interruptions,”
and “without downtime” “are all highly specific claims that are easily capable
of being proven to be true or false through common testing methodologies, and,
by definition, are not puffery.” The puffier statements couldn’t be read in
isolation; it’s the net impression that matters.
Finally, the court declined to stay the action in deference
to the FCC’s “primary jurisdiction” over this suit. This doctrine was irrelevant,
given that the case involved “purely state law claims over which the FCC has
neither jurisdiction nor expertise, and which involves misrepresentations in
advertisements and other media not governed by FCC regulations.” The heart of
the case was not a “complex and technical question[] of engineering and policy,”
but a traditional deceptive practices claim that falls traditionally within the
“conventional competence of courts.”
Even net neutrality repeal didn’t change things; the FCC’s
order said: “[a]lthough we preempt state and local laws that interfere with the
federal deregulatory policy restored in this order, we do not disturb or displace
the states’ traditional role in generally policing such matters as fraud,
taxation, and general commercial dealings, so long as the administration of
such general state laws does not interfere with federal regulatory objectives.”

from Blogger http://ift.tt/2oBpZjy

Posted in Uncategorized | Tagged , | Leave a comment

Reading list: further on global mandatory fair use

Tanya Aplin & Lionel A. F. Bently, Displacing
the Dominance of the Three-Step Test: The Role of Global, Mandatory Fair Use
,
Forthcoming in Wee Loon Ng, Haochen Sun, and Shyam Balganesh (eds) Comparative
Aspects of Limitations and Exceptions in Copyright Law (CUP, 2018).
Article 10(1) of the Berne
Convention mandates a quotation exception that is broad in scope, one that is
not limited by work, nor type of act, nor by purpose, and is only subject to
the conditions in Article 10, namely, the work has been lawfully made available
to the public, attribution, fair practice, and proportionality. We call this
“global, mandatory fair use”. This overlooked norm in international copyright
law is unaffected by and distinct from the three-step test and, as such,
potentially dislodges its dominance. In turn, this creates different
possibilities for how to conceive of and assess copyright exceptions at
national level. To substantiate our argument, this chapter is structured in
three parts. Part I outlines our underpinning contention, namely, that Article
10(1) creates a global, mandatory “fair use” type obligation. Part II explains
why this obligation is unaffected by the three-step test in international
copyright law. Finally, in Part III, we draw out the differences between
Article 10(1) and the three-step test and illustrate the potential relevance of
this for national law using the specific case of U.S. “fair use”.

from Blogger http://ift.tt/2CqDewX

Posted in Uncategorized | Tagged , | Leave a comment

University-adjacent is not university-approved in supplement ads

Obesity Research Institute, LLC v. Fiber Research
International, LLC, 2018 WL 1001089, No. 15-cv-00595 (S.D. Cal. Feb. 21, 2018)
Despite the high-falutin’ names, the parties compete in the
market for glucomannan dietary supplements. Glucomannan is a soluble-viscous
fiber derived from the Konjac plant root used in weight loss supplements. The
parties agree that numerous studies have shown that at least some types of
glucomannan are effective for losing weight, but dispute whether different
types, grades, places of origin, processing procedures, and/or characteristics,
including viscosity, of the specific glucomannan products alter its
effectiveness on weight loss.
ORI’s former products sourced glucomannan from another company, Shimizu. Currently,
ORI sells its supplements branded as Lipozene, which is not manufactured with
Shimizu’s glucomannan.  ORI (with a
supplier) funded a study purporting to find significant weight reductions, of
which 78% was fat, using Shimuzu-supplied glucomannan.  ORI references the study in promoting
Lipozene, characterizing it as a “major university double blind study.”
Lipozene’s packaging stated that there are “[n]o known allergens in this
product.”
Shimizu assigned any false advertising claims it might have
to FRI, as well as the rights to distribute its glucomannan. The court found that FRI had statutory standing under the
Lanham Act to bring claims on behalf of Shimizu.  Though trademark claims require “an interest
in the asset allegedly harmed,” under §43(a) standing is broader.  Under Lexmark,
Shimizu had standing: it invested millions of dollars into developing its
products, and created a relationship with FRI to serve as its newest U.S.
distributor, largely because FRI was in a stronger position to “launch
direct-to-consumer” products than Shimizu, given its location in Japan. Though it
isn’t a direct competitor with Lipozene, Shimizu also distributes glucomannan and
supplies glucomannan to FRI, who seeks to compete with Lipozene in the
glucomannan supplement market. Thus, Shimizu likely suffered an injury to a
commercial interest in reputation or sales and ORI proximately caused Shimizu’s
injuries by using a clinical study analyzing Propol to sell an allegedly inferior
glucomannan product. “Because a valid assignment allows for an assignee to ‘stand
in the shoes’ of the assignor, the Court finds FRI has standing to proceed with
Shimizu’s Lanham Act claim.   
FRI also showed standing to sue on its own
behalf.  FRI’s declarations included
testimony that “[a]s a direct result of ORI’s use of claims derived from the
Propol® studies to sell an inferior product, FRI has been unable to make
inroads into the direct to consumer glucomannan supplement marketplace.” Though
FRI didn’t have a sale when it counterclaimed,
having a sale is not the sole
mechanism for standing under the Lanham Act. The law is clear that a party does
not need to show a loss of sales. Moreover, a lack of sales is consistent with
FRI’s alleged economic injury that it was shut out of the glucomannan
supplement market because of ORI’s false advertisements. Based on the evidence
presented, a reasonable juror could find that FRI sought to enter the
glucomannan supplement market, but found it was blocked from doing so in part
by ORI utilizing a clinical study on its exclusive source of glucomannan.
Though the Court didn’t consider FRI’s post-counterclaim activities
for standing purposes, its later market activities were consistent with its
claims: it registered a website, launched a direct to consumer Propol, and made
a sale.
Falsity: FRI challenged a bunch of ORI’s statements
allegedly based on clinical studies; instead of studying Lipozene, the key
studies (by Kaats & Walsh) evaluated Shimizu’s Propol-branded glucomannan,
a distinct product. ORI disagreed, arguing that the product was the same and
that it used the specifications from the Kaats Study as a guide and “floor” for
the ingredients they ultimately chose. These disputes were best presented to a
jury, so the court denied summary judgment.
ORI also advertised that the Kaats Study is a “major
university study.” But the study was conducted by Dr. Kaats’s then-private
clinical research organization. ORI responded that the study’s design was
approved by Texas Women’s University’s IRB and that two of the named reviewers
of the study were affiliated with two major universities—Georgetown University
and the University of Texas.  Nope.  Kaats stated that he isn’t affiliated with a
major university, that no university was involved in the measurements for the
study, and that he does not consider the study a university study (and even
told ORI to stop calling his study university sponsored).  There was no evidence that IRB involvement “transforms
a study’s sponsorship or affiliation into that of the IRB,” or that a
reviewer’s affiliation with a university allows the study to adopt that
university’s affiliation or sponsorship.  FRI was entitled to summary judgment on the
falsity of this claim.
ORI also advertises that, in the Kaats Study, the test
subjects were “asked not to change their lifestyle” and “asked not to change
their diet or exercise” and lost weight anyway. FRI argued that this statement was
literally false because the test subjects were given no instruction—one way or
another—as to their lifestyle, including diet and exercise. In fact, the study
states that “participants were free to follow any diet/exercise plan of their
own choosing.”  The court found literal
falsity: ORI sought to communicate that study participants “were affirmatively
asked not to change their diet and exercise, implying that any weight lost
while taking Lipozene could not be due to a lifestyle change.” But that message
is not true, although a jury could find it immaterial.
FRI also challenged ORI’s “pure glucomannan” claims such as “Take
pure Glucomannan from the finest Konjac Plants and see results” and “Lipozene
is made with 100% pure Glucomannan, which comes from the root of the Konjac
plant.” Lipozene is made of a combination of ingredients, with the majority
being glucomannan.  No reasonable jury
could find literal falsity—the message was that Lipozine was “made with”
glucomannan, not “made entirely of” glucomannan, and there was no evidence of
actual deception, so that falsity claim was gone.
Finally, ORI claimed that Lipozene contains “no known
allergens,” but FRI argued that it contained excessive sulfite levels, which qualify
as a “known allergen” under FDA regulations. The court couldn’t grant summary
judgment either way; FRI didn’t show that these FDA requirements should apply
to ORI’s statement, and ORI didn’t show that the absence of “major food
allergens” was the same as having “no known allergens.” A jury could find that
this statement only applied to the commonly known major food allergies, such as
nuts, milk, and other common allergies, or that it instead meant additional
irritants, such as sulfites.
Deception: falsity and deception are linked; “[t]he
expenditure by a competitor of substantial funds in an effort to deceive
consumers and influence their purchasing decisions justifies the existence of a
presumption that consumers are, in fact, being deceived.” FRI was entitled summary
judgment as to the deception element of its Lanham Act claim for the “major
university” and “no lifestyle change” statements.
Materiality: The court mostly declined to find that, as a
matter of law, the challenged statements were material, but neither did ORI
show immateriality. For the false-as-a-matter-of-law statements, “major
university study” and “no lifestyle change,” FRI argued that false claims were
presumed to be material, but the court disagreed, and anyway ORI rebutted such
a presumption for the “no lifestyle change” statement by arguing that the
difference between the true and false statements wasn’t material to a consumer.
Though “extensive” empirical evidence isn’t required, FRI needed something.  Nor was “no lifestyle change” an “inherent
quality or characteristic” of the product in the same way as statements
relating to Lipozene’s product composition and proven effects on weight loss.  However, the court did find that no reasonable
jury could find that “major university” was immaterial. “[A] ‘major university’
affiliation invokes a level of legitimacy and assurance for a consumer that
would likely affect a consumer’s decision to purchase Lipozene,” which
accounted for ORI’s desire to have a “university affiliated” study.
Although there was a genuine issue of material fact as to
whether FRI and Shimizu were likely injured, they failed to show irreparable
harm absent injunctive relief. Even assuming the Ninth Circuit would still
presume irreparable harm from falsity [no], ORI rebutted the presumption, so
the issue was best suited for a jury.

from Blogger http://ift.tt/2oBGWdH

Posted in Uncategorized | Tagged | Leave a comment

Crowning inglory: no trade dress in short-lived ads

EZ Pedo, Inc. v. Mayclin Dental Studio, Inc., No.
16-cv-00731, 2018 WL 934552 (E.D. Cal. Feb. 15, 2018)
EZ-Pedo sells “prefabricated pediatric zirconia crowns,”
which are colorless, durable, all-ceramic crowns that mask disfiguration or
stains on children’s teeth. Mayclin sells similar pediatric zirconia crowns
under the business name Kinder Krowns.  EZ-Pedo sued over the copying of several ads
it made from stock photos, but its trade dress claims failed.
EZ-Pedo used the “Beach Girl” ad at the 2014 annual meetings
of the California Society of Pediatric Dentistry and the American Academy of
Pediatric Dentistry; both organizations also featured the Beach Girl
advertisement in their trade journals; and EZ-Pedo displayed the image on
secondary pages of EZ-Pedo’s website. EZ-Pedo alleged that it stopped investing
in this “trade dress” within four months after its first use, after discovering
Kinder Krowns had used it in AAPD’s July 2014 print journal.
EZ-Pedo’s “Gears” design is in an ad that shows a photo of
metal gears plaintiff downloaded from a third-party website; the photograph is
placed beside the slogan, “engineered for a precision fit,” and Kinder Krowns
allegedly copied it to advertise its “Less Prep” crown line on its company
website, causing EZ-Pedo to abandon it after about a year.   The
“Blue CAD” design depicts a computer-aided drawing of a deep-blue-colored tooth
with visible contours. The image was created with 3Shape 3D Viewer, and deep
blue is one of three default color choices. 
The image was featured in print ads, trade-show banners, brochures,
flyers and on its website. Kinder Krowns allegedly copied the Blue CAD trade
dress to advertise its own line of “Less Prep” crowns.    
Beach Girl ads

Blue CAD images

Gears
Promotional flyers/ads could in theory be
covered by trade dress protection; courts have said as much about a website’s
“overall look and feel.” Nonetheless, the burden of establishing protectability
is a serious one.  EZ-Pedo argued that
its ads were inherently distinctive trade dress because each contains
“beautiful, glamorous, fanciful, recognizable” imagery.  But it couldn’t meet the “demanding”
standard; Wal-Mart cautioned against
vague tests for inherent distinctiveness. 
At least inherently distinctive trade dress requires “manifestly unique
arrangements,” and a plaintiff can’t just point at an “overall look”; it must
“articulat[e] the specific elements which comprise its distinct dress.”    EZ-Pedo’s claims couldn’t meet this standard.  For Beach Girl, adjectives like “unique” and
“distinctive” weren’t sufficiently specific. 
“As currently defined, the court and competitors remain in the dark as
to what EZ-Pedo purports to own. Are competitors never to advertise using the
same third-party stock photograph? Can they use the same photograph, but pair
it with different text, logo and company information?” Vague descriptions may
also cause “jurors viewing the same line of products [to] conceive the trade
dress in terms of different elements and features” and so the verdict may drive
from “inconsistent findings.”  

Nor was there a
triable issue on secondary meaning. “Not one of its promotional advertisements
was on the market for more than a year before the alleged infringements
happened.” That was too short, especially given the lack of any consistent
theme in the ads and indeed the drastic differences among them.  Nor were any of the ads ever placed on
EZ-Pedo’s product or product packaging, “further weakening any association.”  And there was no direct evidence of any consumer meaning, let alone meaning
to a substantial portion of consumers.  A
vague, self-serving declaration from EZ-Pedo’s founder that “[t]he pediatric
dentistry community has come to associate the Blue Crown CAD imagery with
EZ-Pedo’s products. I know this…from specific conversations I have had with
purchasing pediatric dentists who have stated they recognize the Blue Crown CAD
as symbolizing our products,” was insufficient. So too with claims of
“thousands” of ads distributed and “substantial time and energy” promoting the
imagery. “[P]rominent display” in a trade journal “is not the kind of media
coverage that shows the ‘enthusiasm and loyalty’ of plaintiff’s customers.”  

from Blogger http://ift.tt/2CondYv

Posted in Uncategorized | Tagged | Leave a comment